Colon cancer screening is only effective if you complete the test. With 53,000 Americans expected to die from colon cancer in ...

Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal ...

A non-invasive, easy-to-use test, like the Cologuard test, is a simple and effective way to screen for colorectal cancer. In ...

With colon cancer rates rising, advocates hope a newly approved blood test screening can help more people catch it early.

Its research also concludes that African Americans have the highest rates of colorectal cancer when compared to any ...

Abu Dhabi health chiefs have hailed the introduction of a blood test for colon cancer as a "game-changer" in the emirate's ...

Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has Option to Commercialize Test Kit Assuming FDA ApprovalBERKELEY ...

Cases of colorectal cancer have been rapidly increasing among young adults, so we spoke to a doctor to get some helpful tips.

New Study Shows at-Home Colon Cancer Screening Test Reduces Risk of Colorectal Cancer Death, as Effective as Screening Colonoscopy July 25, 2024 — A noninvasive colorectal cancer screening test ...

One’s biological age, which measures the body’s physiological state, may help predict who is at risk for developing colon ...

(RTTNews) - Mainz Biomed N.V. (MYNZ), Thursday announced a collaboration with Quest Diagnostics Inc. (DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert ...

The Health Promotion Administration (HPA) is to increase public funding for painless colonoscopy screenings for high-risk ...